IBEX affiliate plans sale of 2,376 shares, $93K

Affiliate Christina Alice Trofimuk O'Connor has filed a Rule 144 notice to sell 2,376 IBEX common shares, following a 7,500-share sale in the prior three months.

Available on EDGAR 09/16/2026 - 01:35 PM EDT Accepted by SEC EDGAR 09/16/2026 - 01:35 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

IBEX Ltd (IBEX) is the issuer of common stock for which affiliate Christina Alice Trofimuk O'Connor has filed a notice of proposed sale under Rule 144. The notice covers the planned sale of 2,376 shares of IBEX common stock through J.P. Morgan Securities LLC on NASDAQ as of September 16, 2026, with an aggregate market value of $93,476.34. IBEX common shares outstanding are reported as 13,389,116 as of that date; this is a baseline figure, not the amount being offered. The notice also reports that O'Connor sold 7,500 shares of IBEX common stock in the prior three months for proceeds of $302,251.82.

Key Figures

Proposed shares to be sold: 2,376 shares Aggregate market value of proposed sale: $93,476.34 Shares outstanding: 13,389,116 shares +2 more

5 metrics

Proposed shares to be sold 2,376 shares IBEX common stock proposed for sale under Rule 144 as of September 16, 2026

Aggregate market value of proposed sale $93,476.34 Value of 2,376 IBEX common shares to be sold as reported

Shares outstanding 13,389,116 shares IBEX common shares outstanding as of September 16, 2026

Shares sold in past three months 7,500 shares IBEX common stock sold on September 15, 2026

Proceeds from past three-month sale $302,251.82 Total consideration for 7,500 IBEX shares sold on September 15, 2026

Key Terms

Rule 144, affiliate, Equity Compensation, PSU Vest, +1 more

5 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

affiliate regulatory

"In addition, information shall be given as to sales by all persons whose sales are required"

Equity Compensation financial

"Common | 10/02/2025 | PSU Vest | IBEX Ltd (Issuer) | | | 2227 | 10/02/2025 | Equity Compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

PSU Vest financial

"Common | 02/06/2026 | PSU Vest | IBEX Ltd (Issuer) |"

attorney in fact regulatory

"as Agent and Attorney in Fact for Christina Alice Trofimuk OConnor"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What sale of IBEX (IBEX) shares is disclosed in this Form 144 notice?

The notice discloses a proposed sale of 2,376 shares of IBEX common stock by affiliate Christina Alice Trofimuk O'Connor through J.P. Morgan Securities LLC on NASDAQ, with an aggregate market value of $93,476.34 as of September 16, 2026.

Who is the selling security holder in this IBEX (IBEX) Form 144?

The selling security holder is Christina Alice Trofimuk O'Connor, identified as an affiliate of IBEX Ltd. J.P. Morgan Securities LLC is named as agent and attorney-in-fact for her in connection with the proposed Rule 144 sale.

How many IBEX (IBEX) shares are outstanding according to the notice?

The notice reports that 13,389,116 shares of IBEX common stock are outstanding as of September 16, 2026. This figure provides context on the company’s equity base and is separate from the 2,376 shares covered by the proposed sale.

What IBEX (IBEX) share sales occurred in the last three months?

The notice states that on September 15, 2026, Christina Alice Trofimuk-O'Connor sold 7,500 shares of IBEX common stock, with total proceeds of $302,251.82. This transaction is reported as sales of securities during the past three months.

What is the relationship between IBEX (IBEX) equity compensation and the securities listed?

The notice lists several IBEX common stock entries tied to PSU Vest and Equity Compensation on dates in 2025 and 2026, indicating performance stock unit vesting events that are associated with IBEX Ltd as issuer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001973684
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	IBEX LIMTED
SEC File Number	001-38442
Address of Issuer	1717 PENNSYLVANIA AVENUE NW SUITE 825 WASHINGTON DISTRICT OF COLUMBIA 20006
Phone	202-580-6200
Name of Person for Whose Account the Securities are To Be Sold	Christina Alice Trofimuk OConnor
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	affiliate

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	J.P. Morgan Securities LLC 270 Park Ave 10th Floor New York NY 10017	2376	93476.34	13389116	09/16/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/02/2025	PSU Vest	IBEX Ltd (Issuer)			2227	10/02/2025	Equity Compensation
Common	02/06/2026	PSU Vest	IBEX Ltd (Issuer)			4343	02/06/2026	Equity Compensation
Common	06/30/2026	PSU Vest	IBEX Ltd (Issuer)			1696	06/30/2026	Equity Compensation
Common	07/01/2026	PSU Vest	IBEX Ltd (Issuer)			1610	07/01/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Christina Alice Trofimuk-O'Connor IBEX LIMTED 1717 PENNSYLVANIA AVENUE NW SUITE 825 WASHINGTON DC 20006	Common	09/15/2026	7500	302251.82

144: Remarks and Signature

Remarks
Date of Notice	09/16/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	J.P. Morgan Securities LLC, Workplace Solutions, as Agent and Attorney in Fact for Christina Alice Trofimuk OConnor, IBEX Limited
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)